Terms: = Liver cancer AND CREB1, ENSG00000118260, 1385 AND Treatment
7 results:
1. Transcriptomic screening of novel targets of sericin in human hepatocellular carcinoma cells.
Jantaravinid J; Tirawanchai N; Ampawong S; Kengkoom K; Somkasetrin A; Nakhonsri V; Aramwit P
Sci Rep; 2024 Mar; 14(1):5455. PubMed ID: 38443583
[TBL] [Abstract] [Full Text] [Related]
2. A novel integrative multi-omics approach to unravel the genetic determinants of rare diseases with application in sinusoidal obstruction syndrome.
Waespe N; Mlakar SJ; Dupanloup I; Rezgui MA; Bittencourt H; Krajinovic M; Kuehni CE; Nava T; Ansari M
PLoS One; 2023; 18(4):e0281892. PubMed ID: 37018234
[TBL] [Abstract] [Full Text] [Related]
3. The outcomes and prognostic factors of patients with hepatocellular carcinoma and normal serum alpha fetoprotein levels.
Fu CC; Wei CY; Chu CJ; Lee PC; Huo TI; Huang YH; Chao Y; Hou MC; Wu JC; Su CW
J Formos Med Assoc; 2023 Jul; 122(7):593-602. PubMed ID: 36456455
[TBL] [Abstract] [Full Text] [Related]
4. Tuftelin 1 Facilitates Hepatocellular Carcinoma Progression through Regulation of Lipogenesis and Focal Adhesion Maturation.
Zhu L; Zhou KX; Ma MZ; Yao LL; Zhang YL; Li H; Du C; Yang XM
J Immunol Res; 2022; 2022():1590717. PubMed ID: 35769513
[TBL] [Abstract] [Full Text] [Related]
5. Long non-coding RNAs HERH-1 and HERH-4 facilitate cyclin A2 expression and accelerate cell cycle progression in advanced hepatocellular carcinoma.
Liu T; Shi Q; Yang L; Wang S; Song H; Wang Z; Xu X; Liu H; Zheng H; Shen Z
BMC Cancer; 2021 Aug; 21(1):957. PubMed ID: 34445994
[TBL] [Abstract] [Full Text] [Related]
6.
Liu X; Zhang H; Zhou P; Yu Y; Zhang H; Chen L; Gong J; Liu Z
Oncol Rep; 2021 May; 45(5):. PubMed ID: 33786634
[TBL] [Abstract] [Full Text] [Related]
7. [Value of mixed embolus transarterial chemoembolization in the treatment of hepatocellular carcinoma].
Li CR; Jiang WH; Feng XM; Guo YJ; Shi ZH; Zhou CW
Zhonghua Zhong Liu Za Zhi; 2005 Sep; 27(9):557-60. PubMed ID: 16438857
[TBL] [Abstract] [Full Text] [Related]
